CD226 and neoplasm: Sayitoglu et al. analysed tumour samples from 32 sarcoma patients and reported that proliferating cell nuclear antigen (PCNA; inhibitory ligand of NKp44) and ligands of DNAM-1, CD112 and CD155, were commonly expressed in these samples [102].